Mutation in the nm23 gene is associated with metastasis in colorectal cancer.

The human nm23 gene, a candidate metastatic suppressor gene, consists of two genes, nm23-H1 and nm23-H2. The potential mutation in the nm23-H1 gene was examined in colorectal cancer using a reverse transcription polymerase chain reaction amplification followed by DNA sequencing analysis. Genomic alterations in the nm23 gene were also examined by Southern hybridization. Genetic alterations either as a deletion in the coding sequence of nm23-H1 or as an allelic deletion were detected in four among eight colorectal adenocarcinomas associated with metastases in lymph nodes, lung, or liver. No alteration was observed in 12 additional colorectal cancer specimens without metastasis. These results provide first evidence for novel mutation in the nm23 gene and demonstrate a correlation between the mutation in the nm23 gene and metastasis in colorectal oncogenesis which suggests that the nm23 gene plays a role in the causation of metastasis.

[1]  L. Liotta,et al.  Somatic allelic deletion of nm23 in human cancer. , 1991, Cancer research.

[2]  Liming Wang,et al.  DNA Polymerase β Mutations in Human Colorectal Cancer , 1992 .

[3]  P. Steeg,et al.  H 2 Gene , nm 23 Identification of a Second Human Updated , 2006 .

[4]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .

[5]  L. Liotta,et al.  Reduced tumor incidence, metastatic potential, and cytokine responsiveness of nm3-transfected melanoma cells , 1991, Cell.

[6]  Y. Honma,et al.  Identity of a differentiation inhibiting factor for mouse myeloid leukemia cells with NM23/nucleoside diphosphate kinase. , 1992, Biochemical and biophysical research communications.

[7]  L. Liotta,et al.  Association of low nm23 RNA levels in human primary infiltrating ductal breast carcinomas with lymph node involvement and other histopathological indicators of high metastatic potential. , 1989, Cancer research.

[8]  L. Liotta,et al.  Nucleoside diphosphate kinases, nm23, and tumor metastasis: possible biochemical mechanisms. , 1992, Cancer treatment and research.

[9]  J. Strahler,et al.  Proliferation-related expression of p19/nm23 nucleoside diphosphate kinase. , 1992, The Journal of clinical investigation.

[10]  M. Rocchi,et al.  The nm23 gene maps to human chromosome band 17q22 and shows a restriction fragment length polymorphism with bg/II , 1992, Genes, chromosomes & cancer.

[11]  J. Willson,et al.  Induction of nm23 gene expression in human colonic neoplasms and equal expression in colon tumors of high and low metastatic potential. , 1991, Journal of the National Cancer Institute.

[12]  I. Lascu,et al.  Nucleoside diphosphate kinase from human erythrocytes: Purification, molecular mass and subunit structure , 1989, FEBS letters.

[13]  K. Mullis,et al.  Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. , 1988, Science.

[14]  F. Sanger,et al.  DNA sequencing with chain-terminating inhibitors. , 1977, Proceedings of the National Academy of Sciences of the United States of America.

[15]  D. Stram,et al.  Evidence for nm23 RNA overexpression, DNA amplification and mutation in aggressive childhood neuroblastomas. , 1993, Oncogene.